Department of Dermatology, University of Arkansas for Medical Sciences, 4301 West Markham St, #576, Little Rock, AR, 72205, USA.
BMC Cancer. 2021 May 3;21(1):492. doi: 10.1186/s12885-021-08142-7.
Mycosis fungoides (MF) is a primary cutaneous T-cell lymphoma (CTCL) that transforms from mature, skin-homing T cells and progresses during the early stages in the skin. The role of the skin microenvironment in MF development is unclear, but recent findings in a variety of cancers have highlighted the role of stromal fibroblasts in promoting or inhibiting tumorigenesis. Stromal fibroblasts are an important part of the cutaneous tumor microenvironment (TME) in MF. Here we describe studies into the interaction of TME-fibroblasts and malignant T cells to gain insight into their role in CTCL.
Skin from normal (n = 3) and MF patients (n = 3) were analyzed for FAPα by immunohistochemistry. MyLa is a CTCL cell line that retains expression of biomarkers TWIST1 and TOX that are frequently detected in CTCL patients. MyLa cells were cultured in the presence or absence of normal or MF skin derived fibroblasts for 5 days, trypsinized to detached MyL a cells, and gene expression analyzed by RT-PCR for MF biomarkers (TWIST1 and TOX), Th1 markers (IFNG, TBX21), Th2 markers (GATA3, IL16), and proliferation marker (MKI67). Purified fibroblasts were assayed for VIM and ACTA2 gene expression. Cellular senescence assay was performed to assess senescence.
MF skin fibroblast showed increased expression of FAP-α with increasing stage compared to normal. Normal fibroblasts co-cultured with MyLa cells suppressed expression of TWIST1 (p < 0.0006), and TOX (p < 0.03), GATA3 (p < 0.02) and IL16 (p < 0.03), and increased expression of IFNG (p < 0.03) and TBX21 (p < 0.03) in MyLa cells. In contrast, MyLa cells cultured with MF fibroblasts retained high expression of TWIST1, TOX and GATA3. MF fibroblasts co-culture with MyLa cells increased expression of IL16 (p < 0.01) and IL4 (p < 0.02), and suppressed IFNG and TBX21 in MyLa cells. Furthermore, expression of MKI67 in MyLa cells was suppressed by normal fibroblasts compared to MF fibroblasts.
Skin fibroblasts represent important components of the TME in MF. In co-culture model, normal and MF fibroblasts have differential influence on T-cell phenotype in modulating expression of Th1 cytokine and CTCL biomarker genes to reveal distinct roles with implications in MF progression.
蕈样肉芽肿(MF)是一种原发性皮肤 T 细胞淋巴瘤(CTCL),起源于成熟的皮肤归巢 T 细胞,并在皮肤早期阶段进展。皮肤微环境在 MF 发展中的作用尚不清楚,但最近在各种癌症中的发现强调了基质成纤维细胞在促进或抑制肿瘤发生中的作用。成纤维细胞是 MF 皮肤肿瘤微环境(TME)的重要组成部分。在这里,我们描述了 TME-成纤维细胞与恶性 T 细胞相互作用的研究,以深入了解它们在 CTCL 中的作用。
通过免疫组织化学分析正常(n=3)和 MF 患者(n=3)皮肤中的 FAPα。MyLa 是一种 CTCL 细胞系,保留了 TWIST1 和 TOX 标志物的表达,这些标志物经常在 CTCL 患者中检测到。MyLa 细胞在存在或不存在正常或 MF 皮肤来源的成纤维细胞的情况下培养 5 天,用胰蛋白酶消化分离 MyLa 细胞,并通过 RT-PCR 分析 MF 生物标志物(TWIST1 和 TOX)、Th1 标志物(IFNG、TBX21)、Th2 标志物(GATA3、IL16)和增殖标志物(MKI67)。纯化的成纤维细胞用于检测 VIM 和 ACTA2 基因表达。进行细胞衰老测定以评估衰老。
与正常皮肤相比,MF 皮肤成纤维细胞的 FAP-α表达随着疾病阶段的增加而增加。与 MyLa 细胞共培养的正常成纤维细胞抑制了 TWIST1(p<0.0006)和 TOX(p<0.03)、GATA3(p<0.02)和 IL16(p<0.03)的表达,并增加了 IFNG(p<0.03)和 TBX21(p<0.03)的表达。相比之下,与 MF 成纤维细胞共培养的 MyLa 细胞保留了 TWIST1、TOX 和 GATA3 的高表达。MF 成纤维细胞与 MyLa 细胞共培养增加了 IL16(p<0.01)和 IL4(p<0.02)的表达,并抑制了 MyLa 细胞中 IFNG 和 TBX21 的表达。此外,与 MF 成纤维细胞相比,正常成纤维细胞抑制了 MyLa 细胞中 MKI67 的表达。
皮肤成纤维细胞是 MF 肿瘤微环境(TME)的重要组成部分。在共培养模型中,正常和 MF 成纤维细胞对 T 细胞表型具有不同的影响,调节 Th1 细胞因子和 CTCL 生物标志物基因的表达,揭示了在 MF 进展中具有不同作用的特征。